Clinical trial
Study Evaluating Metabolic Syndrome in Subjects Undergoing Gastric Bypass…
NCT00283374 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00283374 |
|---|---|
| Title | Study Evaluating Metabolic Syndrome in Subjects Undergoing Gastric Bypass Bariatric Syndrome |
| Official title | A Prospective, Longitudinal Multicenter, Nontreatment, Exploratory Biomarker Study of Metabolic Syndrome in Subjects Undergoing Laparoscopic Roux-En-Y Gastric Bypass Bariatric Syndrome |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Morbid Obesity, Metabolic Disease |
| Intervention type | Procedure |
| Interventions | Laparoscopic Roux-en-Y Gastric Bypass |
| Enrollment | 120 |
| Start date | Oct 1, 2005 |
| First posted | Jan 27, 2006 |
| Last update posted | May 18, 2006 |
| Countries | Italy, Sweden, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: